Showing results (51-60 of 189) with videos related to

Sort By:
Pageof 19
Rheumatology (Oxford, England)|November 23, 2007
Five-year outcome of a primary-care-based inception cohort of patients with inflammatory polyarthritis plus psoriasisC Morgan, M Lunt, D Bunn, et al.
European Journal of Pain (London, England)|June 4, 2014
Self-reported pain severity is associated with a history of coronary heart diseaseS Parsons, J McBeth, G J Macfarlane, et al.
Rheumatology (Oxford, England)|January 24, 2012
Methodological issues when measuring paid productivity loss in patients with arthritis using biologic therapies: an overview of the literatureSuzanne M M Verstappen, Bruno Fautrel, Sabrina Dadoun, et al.
The Journal of Rheumatology|May 8, 2003
National study of cause-specific mortality in rheumatoid arthritis, juvenile chronic arthritis, and other rheumatic conditions: a 20 year followup studyElaine Thomas, Deborah P M Symmons, David H Brewster, et al.
Annals of the Rheumatic Diseases|November 9, 2006
Early functional disability predicts both all-cause and cardiovascular mortality in people with inflammatory polyarthritis: results from the Norfolk Arthritis RegisterTracey M Farragher, Mark Lunt, Diane K Bunn, et al.
Annals of the Rheumatic Diseases|May 7, 2010
Influence of anti-TNF therapy on mortality in patients with rheumatoid arthritis-associated interstitial lung disease: results from the British Society for Rheumatology Biologics RegisterW G Dixon, K L Hyrich, K D Watson, et al.
Rheumatology (Oxford, England)|April 19, 2008
Effects of switching between anti-TNF therapies on HAQ response in patients who do not respond to their first anti-TNF drugK L Hyrich, M Lunt, W G Dixon, et al.
Arthritis and Rheumatism|July 28, 2010
No evidence of association between anti-tumor necrosis factor treatment and mortality in patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics RegisterMark Lunt, Kath D Watson, William G Dixon, et al.
Rheumatology (Oxford, England)|August 19, 2004
The NOAR Damaged Joint Count (NOAR-DJC): a clinical measure for assessing articular damage in patients with early inflammatory polyarthritis including rheumatoid arthritisD K Bunn, L Shepstone, L M Galpin, et al.
Annals of the Rheumatic Diseases|June 11, 2013
Early remission is associated with improved survival in patients with inflammatory polyarthritis: results from the Norfolk Arthritis RegisterCarlo A Scirè, Mark Lunt, Tarnya Marshall, et al.
Pageof 19